1. Sanofi-a Ventis Deutschland Gmbh (16 from 1,827 patents)

2. Sanofi-aventis (11 from 389 patents)

3. Hoechst Aktiengesellschaft (9 from 6,662 patents)

4. Aventis Pharma Deutschland, Gmbh (9 from 330 patents)

5. Sanofi (7 from 1,451 patents)

6. Genzyme Corporation (1 from 787 patents)

1. 11897876 - Isoxazolidines as RIPK1 inhibitors and use thereof

2. 9156796 - Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators

3. 8859494 - Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament

4. 8748465 - Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments

5. 8648038 - (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments

6. 8530413 - Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments

7. 8518875 - (Carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament

8. 8501981 - CXCR2 inhibitors

9. 8236810 - Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV

10. 8207146 - Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical

11. 8163774 - Amide-substituted 8-N-benzimidazoles, method for the production thereof, and use of the same as medicaments

12. 8148375 - (Cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament

13. 8138207 - Aminocarbonyl-substituted 8-N-benzimidazoles, methods for their preparation and their use in pharmaceutical compositions

14. 8003668 - Amino-substituted 8-N-benzimidazoles and methods for their use in blood sugar disorders

15. 7888343 - Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase